Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Ph. D., Doctor en Medicina y Cirugía, Universitat Autònoma de Barcelona (UAB)
Award Date: 23 Jan 1991
Degree, Llicenciat, Universitat Autònoma de Barcelona (UAB)
Award Date: 1 Jan 1984
Fingerprint
Dive into the research topics where Luis Puig-Sanz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
Puig Sanz, L., Iznardo, H., Roé Crespo, E. & Serra-Baldrich, E., 2023, In: Pharmaceutics. 15Research output: Contribution to journal › Review article › Research › peer-review
Open Access -
The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain
Puig Sanz, L., Maravilla-Herrera, P., Merino, M., Alfonso Zamora, S., Balea Filgueiras, J., Carrascosa, J. M., Delgado Sánchez, O., Dolz Sinisterra, F., García-Ruiz, A., Herranz Pinto, P., Manfredi, A., Martínez Olmos, J., Morales de los Ríos Luna, P., Ros Abarca, S. & Hidalgo, Á., 2023, In: Frontiers in Public Health. 11Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Tyk2 Targeting in Immune-Mediated Inflammatory Diseases
Puig Sanz, L. & Rusiñol, L., 2023, In: International Journal of Molecular Sciences. 24Research output: Contribution to journal › Review article › Research › peer-review
Open Access -
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis
Zozaya, N., Abdalla, F., Alfonso Zamora, S., Balea Filgueiras, J., Carrascosa Carrillo, J. M., Delgado Sánchez, O., Dolz Sinisterra, F., García-Ruiz, A., Herranz Pinto, P., Manfredi, A., Martínez Olmos, J., Morales de Los Ríos Luna, P., Puig, L., Ros, S. & HIdalgo-Vega, Á., 25 Apr 2022, In: Expert Review of Pharmacoeconomics and Outcomes Research. 22, 6, p. 941-953 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
Autochthonous and imported tegumentary leishmaniasis in Catalonia (Spain) : Aetiological evolution in the last four decades and usefulness of different typing approaches based on biochemical, molecular and proteomic markers
Puig Sanz, L., Fernández-Arévalo, A., Ballart, C., Muñoz-Basagoiti, J., Basarte, L., Lobato, G., Arnau, A., Abras, A., Tebar, S., Llovet, T., Lami, P., Pratlong, F., Alsina, M., Roé Crespo, E., Muñoz-Batet, C. & Gállego, M., 2022, In: Transboundary and Emerging Diseases. 69, 3, p. 1404-1418 15 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access
Thesis
-
Modulación farmacológica y dietética del metabolismo del ácido araquidónico. Implicaciones en la psoriasis
Author: Puig Sanz, L., 21 Jan 1991Supervisor: de Moragas, J. M. (External person) (Director)
Student thesis: Doctoral thesis
Datasets
-
Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate to Severe Plaque Psoriasis: A Machine Learning Predictive Model
Papp, K. A. (Creator), Soliman, A. M. (Creator), Done, N. (Creator), Carley, C. (Creator), Lemus Wirtz, E. (Contributor) & Puig-Sanz, L. (Creator), Adis Journals, 18 May 2021
DOI: 10.6084/m9.figshare.14541864.v1, https://adisjournals.figshare.com/articles/media/Deterioration_of_Health-Related_Quality_of_Life_After_Withdrawal_of_Risankizumab_Treatment_in_Patients_with_Moderate_to_Severe_Plaque_Psoriasis_A_Machine_Learning_Predictive_Model/14541864/1
Dataset
-
Urine metabolome profiling of immune-mediated inflammatory diseases
Julià, A. (Creator), Vinaixa, M. (Creator), Domènech, E. (Creator), Fernández-Nebro, A. (Creator), Cañete, J. D. (Creator), Ferrándiz, C. (Creator), Tornero, J. (Creator), Gisbert, J. P. (Creator), Nos, P. (Creator), Casbas, A. G. (Creator), Puig-Sanz, L. (Contributor), González-Álvaro, I. (Creator), Pinto-Tasende, J. A. (Creator), Blanco, R. (Creator), Rodríguez, M. A. (Creator), Beltran, A. (Creator), Correig, X. (Creator), Marsal, S. (Creator) & Alonso, A. (Contributor), figshare, 8 Sept 2016
DOI: 10.6084/m9.figshare.c.3643964.v1, https://figshare.com/collections/Urine_metabolome_profiling_of_immune-mediated_inflammatory_diseases/3643964/1
Dataset
-
Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials
Chabra, S. (Creator), Gill, B. J. (Creator), Gallo, G. (Creator), Zhu, D. (Creator), Pitou, C. (Creator), Payne, C. D. (Contributor), Accioly, A. (Creator) & Puig-Sanz, L. (Creator), Adis Journals, 26 Jul 2022
DOI: 10.6084/m9.figshare.20377029.v1, https://adisjournals.figshare.com/articles/media/Ixekizumab_Citrate-Free_Formulation_Results_from_Two_Clinical_Trials/20377029/1
Dataset
-
Urine metabolome profiling of immune-mediated inflammatory diseases
Julià, A. (Creator), Vinaixa, M. (Creator), Domènech, E. (Creator), Fernández-Nebro, A. (Creator), Cañete, J. D. (Creator), Ferrándiz, C. (Creator), Tornero, J. (Creator), Gisbert, J. P. (Creator), Nos, P. (Creator), Casbas, A. G. (Creator), Puig-Sanz, L. (Contributor), González-Álvaro, I. (Creator), Pinto-Tasende, J. A. (Creator), Blanco, R. (Creator), Rodríguez, M. A. (Creator), Beltran, A. (Creator), Correig, X. (Creator), Marsal, S. (Creator) & Alonso, A. (Contributor), figshare, 9 Aug 2016
DOI: 10.6084/m9.figshare.c.3643964, https://figshare.com/collections/Urine_metabolome_profiling_of_immune-mediated_inflammatory_diseases/3643964
Dataset
-
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis
Zozaya, N. (Creator), Abdalla, F. (Creator), Alfonso Zamora, S. (Contributor), Balea Filgueiras, J. (Contributor), Carrascosa Carrillo, J. M. (Contributor), Delgado Sánchez, O. (Contributor), Dolz Sinisterra, F. (Contributor), García-Ruiz, A. (Creator), Herranz Pinto, P. (Contributor), Manfredi, A. (Creator), Martínez Olmos, J. (Contributor), Morales de Los Ríos Luna, P. (Contributor), Puig-Sanz, L. (Creator), Ros, S. (Creator) & HIdalgo-Vega, Á. (Creator), 25 Apr 2022
DOI: 10.6084/m9.figshare.19651220.v1, https://tandf.figshare.com/articles/dataset/Assessing_the_value_contribution_of_bimekizumab_for_the_treatment_of_moderate-to-severe_psoriasis_using_a_multidisciplinary_reflective_multi-criteria_decision_analysis/19651220/1
Dataset